AKT1 and chronic obstructive pulmonary disease: To verify the above speculation on the anti-COPD pharmacological mechanism of ISOF, firstly, the expression of 16 DEGs (Fig. 2D) involved in the PI3K/AKT pathway (KEGG database) was examined in lung tissue from rats with CS-induced COPD.